Your browser doesn't support javascript.
loading
Azithromycin to prevent bronchopulmonary dysplasia in ureaplasma-infected preterm infants: pharmacokinetics, safety, microbial response, and clinical outcomes with a 20-milligram-per-kilogram single intravenous dose.
Viscardi, Rose M; Othman, Ahmed A; Hassan, Hazem E; Eddington, Natalie D; Abebe, Elias; Terrin, Michael L; Kaufman, David A; Waites, Ken B.
Affiliation
  • Viscardi RM; Department of Pediatrics, University of Maryland School of Medicine, Baltimore, Maryland, USA. rviscard@umaryland.edu
Antimicrob Agents Chemother ; 57(5): 2127-33, 2013 May.
Article in En | MEDLINE | ID: mdl-23439637
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Respiratory System / Ureaplasma / Bronchopulmonary Dysplasia / Infant, Premature / Models, Statistical / Azithromycin / Anti-Bacterial Agents Type of study: Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male / Newborn Language: En Journal: Antimicrob Agents Chemother Year: 2013 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Respiratory System / Ureaplasma / Bronchopulmonary Dysplasia / Infant, Premature / Models, Statistical / Azithromycin / Anti-Bacterial Agents Type of study: Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male / Newborn Language: En Journal: Antimicrob Agents Chemother Year: 2013 Document type: Article Affiliation country: Country of publication: